Abstract
An 11-year-old boy with chronic granulomatous disease caused by cytochrome b deficiency developed right upper lung lobe aspergillosis. Intracerebral lesions developed on maximum doses of flucytosine and amphotericin B. Treatment with 16 mg/kg oral itraconazole was followed by a dramatic clinical improvement and almost complete disappearance of the intracerebral lesions. Plasma itraconazole levels were between 40 and 3440 ng/ml depending on concomitant medication. Toxicity was restricted to transient elevation of alkaline phosphatase and gamma glutamyl transferase. We conclude that further trials with itraconazole are justified in high risk patients in whom conventional therapy has failed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- APh:
-
alkaline phosphatase
- CGD:
-
chronic granulomatous disease
- gGT:
-
gamma glutamyl transferase
- NBT:
-
nitroblue tetrazolium dye
References
Cohen M, Isturiz RE, Malech HL, Root RK (1981) Fungal infection in chronic granulomatous disease. Am J Med 71:59–66
Denning D, Tucker R, Hanson L, Stevens D (1989) Treatment of invasive aspergillosis with itraconazole. Am J Med 86:791–800
Dupont B, Drouhet E (1987) Early experiences with itraconazole in vitro and in patients: pharmacokinetic studies and clinical results. Rev Infect Dis 9; S1: 71–76
Fanconi S, Seger R, Gmür J, Willi U, Schaer G, Spiess H, Otto R, Hitzig WH (1985) Surgery and granulocyte transfusions for life-threatening infections in chronic granulomatous disease. Helv Paediatr Acta 40:277–284
Frayha HH, Biggar WD (1983) Chronic granulomatous disease of childhood: a changing pattern? J Clin Immunol 3:287–291
Goodpasture HC, Hershberger RE, Barnett AM, Peterie JD (1985) Treatment of central nervous system fungal infection with ketoconazole. Arch Int Med 145:879–880
Kwong YL, Yu YL, Chan FL, Lam KSL, Woo E, Huang CY (1987) High dose ketoconazole in the treatment of cerebral aspergilloma. Clin Neurol Neurosurg 89:193–196
Longman LP, Martin WV (1987) A comparison of the efficacy of itraconazole, amphotericin B and 5-fluorocytosine in the treatment ofAspergillus fumigatus endocarditis in the rabbit. J Antimicrob Chemother 20:719–724
Mouy R, Bremard C, Fischer A, Huu Trong P, Vilmer E, Griselli C (1985) Infection aspergillaire et granulomatose septique chronique. Arch Fr Pediatr 42:953–957
Neijens H, Frenkel J, Muinck Keizer-Schrama S de, Dzoljic-Danilovic G, Meradji M, Dongen J van (1989) Invasive aspergillus infection in chronic granulomatous disease: treatment with itraconazole. J Pediatr 115, 6:1016–1019
Partridge B, Chin A (1981) Cerebral aspergilloma. Postgrad Med J 57:439–442
Phillips P, Fetchick R, Weisman I, Foshee S, Graybill J (1987) Tolerance to and efficacy of itraconazole in the treatment of systemic mycoses: preliminary results. Rev Infect Dis 9; S1: 87–93
Pollack IF, Pang D, Schuit KE (1987) Chronic granulomatose disease with cranial fungal osteomyelitis and epidural abscess. J Neurosurg 67:132–136
Raper KB, Fenell DJ (1965) The genus Aspergillus. Williams, Wilkins Comp, Baltimore
R 51211 Itraconazole. Basic medical information brochure. May 1986-5th edn. Janssen Research Foundation Beerse Belgium
Seger R, Baumgartner S, Tiefenauer L, Gmünder F (1981) Chronic granulomatous disease: effect of sulfamethoxazole/trimethoprim on neutrophil microbicidal function. Helv Paediatr Acta 36:579–588
Tricot G, Joosten E, Boogaerts MA, Vande Pitte J, Cauwenbergh G (1987) Ketoconazole vs. itraconazole for antifungal prophylaxis in patients with severe granulocytopenia: preliminary results of two nonrandomised studies. Rev Infect Des 9: S1:94–99
Van Cutsem J, Van Gerven F, Van de Ven M, Borgers M (1984) Itraconazole, a new triazole that is orally active in aspergillosis. Antimicrob Agents Chemother 24:527–534
Walsh TJ, Hier DB, Caplan LR (1985) Aspergillosis of the central nervous system: clinicopathological analysis of 17 patients. Ann Neurol 18:574–582
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kloß, S., Schuster, A., Schroten, H. et al. Control of proven pulmonary and suspected CNS aspergillus infection with itraconazole in a patient with chronic granulomatous disease. Eur J Pediatr 150, 483–485 (1991). https://doi.org/10.1007/BF01958428
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01958428